Login to Your Account



Three-Year Data Suggest Broader Provenge Label In Prostate Cancer

By Aaron Lorenzo


Friday, October 29, 2004
Boosting hopes for a wider label than previously thought, Dendreon Corp. released final three-year follow-up data from a Phase III study of Provenge. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription